CHPA’s Bierer
This article was originally published in The Tan Sheet
Executive Summary
Douglas Bierer, PhD, is resigning from his post as VP - Regulatory & Scientific Affairs for personal reasons, the Consumer Healthcare Products Association announces July 22. "I've enjoyed my time with CHPA and have high hopes for where the Association is going," Bierer said, though he admits "the weekly commute between CHPA's offices in D.C. and my family in Ohio has been difficult." Bierer has worked in the OTC industry for nearly 30 years and plans to remain involved with the association following his departure July 28. Lorna Totman, PhD, senior director, scientific affairs & toxicology, will serve as acting VP of the department until Bierer's permanent replacement is hired...
You may also be interested in...
CHPA appointment
Heinz Schneider, MD, will assume his new role as VP-Regulatory & Scientific Affairs July 1, the Consumer Healthcare Products Association announces May 5. Schneider most recently served as head of international regulatory affairs at Boots Healthcare International from 2004-2006, and was named global director of regulatory, safety and environment after BHI was acquired by Reckitt Benckiser in October. He takes the place of Doug Bierer, who left CHPA in July (1"The Tan Sheet" July 25, 2005, In Brief)...
China Biotechs, CDMOs Embrace Uncertain Future, New Options Amid WuXi Woes
The shockwave of WuXi's withdrawal from BIO is ripping through the Chinese contract services sector. While some remain hopeful, others are preparing Plan B.
US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments
FDA’s efforts to tackle misinformation may face fewer legal obstacles moving forward, following oral arguments at the Supreme Court on a case that could have broad ramifications for how the government communicates public health information.